Lucid Diagnostics shareholders re-elect Lapidus and Sokolov, approve stock issuance, ratify auditor

Lucid Diagnostics Inc.

70.9% of shares represented at June 18 annual meeting; all management proposals passed.
Class A directors Stanley N. Lapidus and Jacque J. Sokolov re-elected with ~63.8M votes each.
Issuance of shares under 2024 Convertible Notes approved: 69.6M for, 0.62M against.
Ratification of CBIZ CPAs P.C. as auditor for FY2025: 90.0M for, 0.2M against.

item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.